Phase II Study of a Combination Chemotherapy of DICE in the Patients With NK/T Cell Lymphoma
Patients with NK/T cell lymphoma usually have a bad prognosis. These patients cannot be
treated successfully with the conventional chemotherapy of CHOP.The investigators did this
trial to evaluate the efficacy and tolerability of the combination chemotherapy of DICE in
the patients with NK/T cell lymphoma.
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
every two cycles
Ye Guo, M.D.
China: Ethics Committee